14.08.2015 • News

GSK Says Drugs from Closed Plant Safe

Drugs produced at a GlaxoSmithKline pharmaceutical plant in North Carolina closed earlier this week are safe, the company said, adding that production is due to restart by the beginning of next week.

The plant at Zebulon east of Raleigh manufactures inhaled medications. It was closed after routine testing found Legionella bacteria in two external cooling towers. "No employees are sick and no products have been compromised," a GSK spokesperson said. "Medicines were not exposed to the bacteria."

North Carolina health officials said no cases of Legionnaires' disease linked to the Glaxo plant have been reported. But GSK said the building was closed because the cooling towers maintain temperature and humidity needed for manufacturing and working conditions.

The US Food and Drug Administration was still looking into the incident on Thursday.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.